Canadians have heard little from any political party in the election campaign about how they will improve access to innovative medicines that can provide...
OTTAWA, ON (June 3, 2021): The COVID-19 pandemic has unmasked a dangerous lack of investment in pharmaceutical and vaccine research, development, and manufacturing in Canada....
For those aged 85 and above—our most vulnerable population—Canada’s situation is deteriorating with its excess death rate for Canada at 18.0 per cent,...
OTTAWA, ON (December 21, 2020): In our December issue, the Macdonald-Laurier Institute normally names the person or institution that has had the greatest impact...
Like masks, vaccination creates “positive externalities.” If lots of people resist vaccination, that hurts the rest of us, who might catch the disease...
*NOTE: due to technical challenges, a portion of the livestream was lost, particularly the opening remarks from MLI Munk Senior Fellow Richard...
Economics simply trotted out the same easy-money and deficit-financed policies it has relentlessly pursued since the financial crisis, writes Philip Cross in the...
In the absence of COVID testing capacity, it is important to identify the most common problems in communities and the interventions that are...
An old idea for a short-cut to cheaper medicines in the US seems to be gaining momentum in 2019. President Donald Trump and...
Socialized medicine was sold on the promise to provide care, yet Canada has fallen short of providing timely patient care. Since health care won’t...